MedTrace Logo

Nutritional Therapy Enriched With Omega-3 in Patients With Lung Resection

NCT06531460 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 310

Last updated 2024-08-01

No results posted yet for this study

Summary

The aim of this study is to analyze the effect of enriched formula with omega-3 in the 30-day incidence infection and inflammatory response following lung resection surgery in lung cancer patients.

Conditions

Interventions

DIETARY_SUPPLEMENT

Fish oil enteral supplementation

Omega-3 (4.2 g), administered through an enteral feeding tube, three days before surgery

DIETARY_SUPPLEMENT

Fish oil oral supplementation

Omega-3 (4.2 g), orally administered enriched nutritional formula, drinking at home three days before surgery

DIETARY_SUPPLEMENT

Enteral nutrition without fish oil

Enteral formula without omega-3 administered through an enteral feeding tube, three days before surgery

DIETARY_SUPPLEMENT

Oral nutritional supplement without fish oil

Oral nutritional supplement without omega-3 orally administered, drinking at home three days before surgery

Sponsors & Collaborators

  • National Institute of Respiratory Diseases, Mexico

    lead OTHER_GOV

Principal Investigators

  • Ivan A Osuna-Padilla, PhD · Instituto Nacional de Enfermedades Respiratorias

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-07-25
Primary Completion
2026-12-31
Completion
2027-07-31

Countries

  • Mexico

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06531460 on ClinicalTrials.gov